rs193922401
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
|
|
|
rs80356611
|
|
T |
0.710 |
GeneticVariation |
CLINVAR |
|
|
|
rs141322087
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922396
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922397
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922399
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922400
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922403
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922406
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922407
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922408
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193922565
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs80356663
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs193929375
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We describe a novel homozygous missense glucokinase mutation (R397L) resulting in insulin-treated neonatal diabetes in an infant from a consanguineous Asian family.
|
15644838 |
2005 |
rs193929373
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To investigate the prevalence and clinical characteristics of heterozygotes of the glucokinase gene mutations G264S and IVS8+2 in the extended pedigree of two patients with permanent neonatal diabetes as a result of glucokinase deficiency (IVS8+2 homozygosity and IVS8+2/G264S compound heterozygosity).
|
16026363 |
2005 |
rs80356624
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We identified KCNJ11 mutations in four of 10 probands with permanent neonatal diabetes and one affected parent; this included the novel C166F mutation and the previously described V59M and R201H.
|
16670688 |
2006 |
rs80356616
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We identified KCNJ11 mutations in four of 10 probands with permanent neonatal diabetes and one affected parent; this included the novel C166F mutation and the previously described V59M and R201H.
|
16670688 |
2006 |
rs80356618
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We identified KCNJ11 mutations in four of 10 probands with permanent neonatal diabetes and one affected parent; this included the novel C166F mutation and the previously described V59M and R201H.
|
16670688 |
2006 |
rs80356611
|
|
|
0.710 |
GeneticVariation |
BEFREE |
We identified a novel KCNJ11 mutation, R50Q, that causes permanent neonatal diabetes (PNDM) without neurological problems.
|
16731833 |
2006 |
rs1285524167
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We report the response to sulfonylurea treatment in a boy with neonatal diabetes and marked developmental delay resulting from the KCNJ11 mutation V59M.
|
17047922 |
2006 |
rs80356616
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We report the response to sulfonylurea treatment in a boy with neonatal diabetes and marked developmental delay resulting from the KCNJ11 mutation V59M.
|
17047922 |
2006 |
rs80356624
|
|
|
0.030 |
GeneticVariation |
BEFREE |
This is consistent with the ability of the R201H mutation to cause neonatal diabetes in patients.
|
17065345 |
2006 |
rs193929355
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We assessed the functional effects of two Kir6.2 mutations associated with ND: K170T and E322K.
|
17919178 |
2007 |
rs193922401
|
|
|
0.710 |
GeneticVariation |
BEFREE |
Here we investigate the molecular mechanism by which two heterozygous mutations in the second nucleotide-binding domain (NBD2) of SUR1 (R1380L and R1380C) separately cause neonatal diabetes.
|
18025464 |
2007 |
rs137852673
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Here we investigate the molecular mechanism by which two heterozygous mutations in the second nucleotide-binding domain (NBD2) of SUR1 (R1380L and R1380C) separately cause neonatal diabetes.
|
18025464 |
2007 |